Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma
Joint Authors
Parekh, Samir
Sparano, Joseph A.
Petrich, Adam M.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-04-18
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Burkitt lymphoma (BL) is a very aggressive subtype of non-Hodgkin's lymphoma that occurs with higher frequency in patients with HIV/AIDS.
Patients with HIV-related BL (HIV-BL) are usually treated with high-intensity, multi-agent chemotherapy regimens.
The addition of the monoclonal antibody Rituximab to chemotherapy has also been studied in this setting.
The potential risks and benefits of commonly used regimens are reviewed herein, along with a discussion of controversial issues in the practical management of HIV-BL, including concurrent anti-retroviral therapy, treatment of relapsed and/or refractory disease, and the role of stem cell transplantation.
American Psychological Association (APA)
Petrich, Adam M.& Sparano, Joseph A.& Parekh, Samir. 2012. Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma. Advances in Hematology،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-469311
Modern Language Association (MLA)
Petrich, Adam M.…[et al.]. Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma. Advances in Hematology No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-469311
American Medical Association (AMA)
Petrich, Adam M.& Sparano, Joseph A.& Parekh, Samir. Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma. Advances in Hematology. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-469311
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-469311